Rahul Manu Kohli MD PhD
Assistant Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3400 Spruce Street3 Silverstein Bldg Suite DPhiladelphia, PA 19104
Phone+1 215-662-6932
Dr. Kohli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 2006 - 2010
University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2006
Harvard Medical SchoolClass of 2004
Certifications & Licensure
PA State Medical License 2004 - 2026
MD State Medical License 2009 - 2010
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsScalable Screening of Ternary-Code DNA Methylation Dynamics Associated with Human Traits.David C Goldberg, Cameron Cloud, Sol Moe Lee, Bret Barnes, Steven Gruber
Biorxiv. 2025-02-11 - 1 citationsNeomorphic leukemia-derived mutations in the TET2 enzyme induce genome instability via a substrate shift from 5-methylcytosine to thymine.Guang-Bo Jin, Shao-Qin Rong, Dong-Rui Yin, Zhou-Hao Deng, Xiao Ding
Proceedings of the National Academy of Sciences of the United States of America. 2025-02-04 - TET1 displays catalytic and non-catalytic functions in the adult mouse cortex.Yee Hoon Foong, Blake Caldwell, Joanne L Thorvaldsen, Christopher Krapp, Clementina A Mesaros
Epigenetics. 2024-12-01
Journal Articles
- Disruption of TET2 Promotes the Therapeutic Efficacy of CD19-Targeted T CellsShannon A Carty, Carl H June, David L Porter, Bruce L Levine, Rahul M Kohli, Nature
Press Mentions
Gene Editing Method Could Power New Cell Gene TherapiesApril 29th, 2023- Improved Gene Editing Method Could Power the Next Generation of Cell and Gene TherapiesApril 28th, 2023
DNA Deaminase-Based Hydroxymethyl–Seq: Nondestructive and Base-ResolutionJune 4th, 2019- Join now to see all
Grant Support
- Medical Scientist Training ProgramUNIVERSITY OF PENNSYLVANIA2023–2028
- Inhibition and Catalytic Degradation of Promutagenic DNA DeaminasesUNIVERSITY OF PENNSYLVANIA2023–2025
- Engineering Efficient and Controllable Base EditorsUNIVERSITY OF PENNSYLVANIA2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
